Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 ...
-
Time-Sensitive: Allegations Focus on Concealed Enterprise Sales Cycle Deterioration MNDY INVESTOR ALERT NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in...
-
Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative outcomes in a modern post-transplant cyclophosphamide (PTCy) era MINNEAPOLIS,...
-
The global hydrogen fuel cell recycling market was valued at $358.7 million in 2024 and is projected to reach $762.4 million by the end of 2030.
-
BENGALURU, KA, March 23, 2026 (GLOBE NEWSWIRE) -- BENGALURU, KA - March 23, 2026 - - As housing costs in Mumbai continue to rise and workforce mobility accelerates, a growing number of urban...
-
CHICAGO, IL, March 23, 2026 (GLOBE NEWSWIRE) -- The rise of GLP‑1 medication usage is emerging as a transformational force in the U.S. apparel industry. As millions of Americans experience changes...
-
MOUNTAIN VIEW, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and...
-
Austin, United States, March 23, 2026 (GLOBE NEWSWIRE) -- Ophthalmic Diagnostic Devices Market Size & Growth Analysis: According to SNS Insider, The Ophthalmic Diagnostic Devices Market size...
-
– Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC – –...
-
RENO, Nev., March 23, 2026 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (“Company” or “Ormat”) today announced the closing of its previously announced private offering of $1 billion...